Company Overview of KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. develops and commercializes therapeutic cancer vaccines and infectious disease vaccines. It provides lung, melanoma, leukemia, pancreatic, prostate, and breast/ovarian cancer vaccines; and malaria, HIV, hepatitis, and influenza diseases vaccines. KAEL-GemVax Co., Ltd. was formerly known as GemVax Co., Ltd. The company was founded in 2001 and is based in Seongam-si, South Korea. KAEL-GemVax Co., Ltd. operates as a subsidiary of GemVax & Kael Co., Ltd.
3rd Floor GemVax Tower
Founded in 2001
82 2 544 6221
82 2 3443 4997
Key Executives for KAEL-GemVax Co., Ltd.
Similar Private Companies By Industry
|Korea Otsuka Pharmaceutical Co., Ltd.||Asia|
|Daiichi Pharmaceutical Korea Co., Ltd.||Asia|
|Unigen Co., Ltd.||Asia|
|Sam-Oh Pharm Co., Ltd.||Asia|
|Berna Biotech Korea Corp.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact KAEL-GemVax Co., Ltd., please visit www.kaelgemvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.